The Institute of Molecular Genetics of Montpellier
is a multidisciplinary institute for advanced studies in biology. It has an internationally-acknowledged reputation in the fields of genetic and epigenetic regulations, RNA biology as well as cell cycle, death and metabolism. Its work also has impact in biomedical research on cancer, infectious illnesses and genetic diseases via the development of novel biotherapies and diagnostic tools as well as the launching of biotech start-up companies.
Interview in The Scientist
Joe McKellar (Karim Majzoub team) shares in The Scientist his work on deltaviruses and cell imaging, ranging from human cells to boa constrictor cells…
Lumière sur le développement : pourquoi agir au bon moment est-il crucial ?
Quand chaque minute compte : une étude dévoile le rôle crucial du timing dans l’activation des gènes embryonnaires…..
When the body plan is written in two voices: DNA and RNA, a new score of gene regulation
New publication from Julie Carnesecchi’s team in Nucleic Acids Research …
How DNA secondary structures signal gene start sites for transcription initiation
In a study published in Nature Genetics, the team of Jean-Christophe Andrau and collaborators demonstrates….
A Major Scientific Breakthrough from the Abivax Joint Laboratory and the Tazi Team at IGMM
A milestone reached in the fight against ulcerative colitis…
OPEN CALL FOR GROUP LEADERS IN INNOVATIVE BIOLOGY
Open Positions: Internships, PhD Thesis, Post-Docs, Technicians, Engineers
IGMM has a long-standing tradition of training by and for research. Thus, all groups are used to host students at different stages of their cursus, including PhD Thesis. They also welcome Post-Docs, Engineers and Technicians.